A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors

por Wei, Yuming, Poon, Daniel C., Fei, Rong, Lam, Amy S. M., Au-Yeung, Steve C. F., To, Kenneth K. W.
Publicado 2016